No Data
No Data
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Ascendiant Maintains Aclarion(ACON.US) With Buy Rating, Cuts Target Price to $1.3
Express News | Ascendiant Capital Maintains Buy on Aclarion, Lowers Price Target to $1.3
Aclarion Analyst Ratings
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
No Data